TotalMarketCap

Tyra Biosciences

TYRANasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$1.431 B

$20.82 -3.30%

Close of 6 Nov 2026

As of 6 Nov 2026, Tyra Biosciences (TYRA) has a market capitalization of $1.43B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$119.9M

Loss-making

Shares outstanding

59,676,939

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #116Pacira BioSciencesPCRX$1.45B
  2. #117Phibro Animal HealthPAHC$1.44B
  3. #118Tyra BiosciencesTYRA$1.43B
  4. #119Ocular TherapeutixOCUL$1.41B
  5. #120Ascentage Pharma Group InternationalAAPG$1.41B

What if Tyra Biosciences were worth as much as…

Open the what-if tool →

Gold $28.2T

$410,682.69

Per share 19,730× higher

Bitcoin $1.53T

$22,221.33

Per share 1,068× higher

Apple $5.02T

$72,950.54

Per share 3,505× higher

Or at a round number

$2.00B$5.00B$10.0B$20.0B

Where these numbers come from

Share counts and financials for Tyra Biosciences are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.